These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 3667552

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Conformational studies by 1H nuclear magnetic resonance of the trypsin-chymotrypsin inhibitor B-III from peanuts and its enzymatically modified derivative.
    Koyama S, Kobayashi Y, Norioka S, Kyogoku Y, Ikenaka T.
    Biochemistry; 1986 Dec 02; 25(24):8076-82. PubMed ID: 3542043
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Purification and characterization of peptidylarginine deiminase from rabbit skeletal muscle.
    Takahara H, Oikawa Y, Sugawara K.
    J Biochem; 1983 Dec 02; 94(6):1945-53. PubMed ID: 6671973
    [Abstract] [Full Text] [Related]

  • 28. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK, Hinkers SC.
    J Agric Food Chem; 2004 Jun 30; 52(13):4219-26. PubMed ID: 15212472
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
    Scheidig AJ, Hynes TR, Pelletier LA, Wells JA, Kossiakoff AA.
    Protein Sci; 1997 Sep 30; 6(9):1806-24. PubMed ID: 9300481
    [Abstract] [Full Text] [Related]

  • 31. Deimination of glycogen phosphorylase b by peptidylarginine deiminase. Influence on the kinetical characteristics and dimer-tetramer transition.
    Eronina TB, Livanova NB, Chebotareva NA, Kurganov BI, Luo S, Graves DJ.
    Biochimie; 1996 Sep 30; 78(4):253-8. PubMed ID: 8874800
    [Abstract] [Full Text] [Related]

  • 32. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
    Wood DD, Ackerley CA, Brand Bv, Zhang L, Raijmakers R, Mastronardi FG, Moscarello MA.
    Lab Invest; 2008 Apr 30; 88(4):354-64. PubMed ID: 18227806
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II).
    Swaim MW, Pizzo SV.
    Biochem J; 1988 Aug 15; 254(1):171-8. PubMed ID: 2460086
    [Abstract] [Full Text] [Related]

  • 40. Engineering the S1' subsite of trypsin: design of a protease which cleaves between dibasic residues.
    Kurth T, Grahn S, Thormann M, Ullmann D, Hofmann HJ, Jakubke HD, Hedstrom L.
    Biochemistry; 1998 Aug 18; 37(33):11434-40. PubMed ID: 9708978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.